Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus rhamnosus GG for prevention of acute phases in allergic conjunctivitis
2007-000209-31Phase 2Active
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Apr 2007
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of Lactobacillus rhamnosus GG in allergic conjunctivitis (AC), sponsored by Università Campus Bio-Medico di Roma. Primary endpoint: Number of acute phases. Started Apr 2007; status: active.
02
Drugs
Lactobacillus rhamnosus GG
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on 2007-000209-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000209-31.